Ignite Creation Date:
2025-12-25 @ 4:38 AM
Ignite Modification Date:
2026-01-10 @ 12:26 AM
Study NCT ID:
NCT03242018
Status:
COMPLETED
Last Update Posted:
2021-06-25
First Post:
2017-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
Sponsor:
Lexicon Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-03
First Submit QC Date:
None
Study First Post Date:
2017-08-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-16
Results First Submit QC Date:
None
Results First Post Date:
2021-06-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-06-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-06-03
Last Update Post Date:
2021-06-25
Last Update Post Date Type:
ACTUAL